Navigation Links
Ching-Hon Pui, M.D., honored by the American Society of Hematology for work in childhood cancer
Date:7/7/2011

Ching-Hon Pui, M.D., an eminent leader in the research and treatment of pediatric leukemia at St. Jude Children's Research Hospital, has been named the recipient of the 2011 Henry M. Stratton Medal from the American Society of Hematology (ASH). The award recognizes the progress Pui has made in the fight against this blood cancer during the past three decades.

Named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH's journal Blood, the award honors a senior investigator whose contributions to hematology are well recognized and have taken place over a period of several years. Pui will accept the medal in December during the 53rd ASH Annual Meeting and Exposition in San Diego.

"Dr. Pui has dedicated his career to advancing the research and treatment of pediatric leukemia," said Dr. William E. Evans, St. Jude director and CEO. "This honor recognizes his leadership contributions as a translational researcher, physician and educator. His work has shaped how pediatric leukemia is treated worldwide."

Pui has played a central role in a series of treatment protocols responsible for raising cure rates of acute lymphoblastic leukemia (ALL), the most common childhood cancer, from about 70 percent in the early 1980s to an unprecedented 90 percent at St. Jude today. His work has shown that cranial irradiation, once regarded as a standard treatment for childhood ALL, can be omitted altogether, thus sparing patients from devastating side effects and enhancing their quality of life. More recently, his treatment approach resulted in a remarkably high cure rateapproaching 90 percentin older adolescents with ALL.

Pui's team also pioneered the use of pharmacodynamics and pharmacogenetics to individualize chemotherapy and to optimize the use of existing drugs. He and his colleagues also have used genome-wide analysis to accurately classify leukemias, to identify cooperative genetic mutations of leukemic cells and molecular targets for therapy, and to identify host genes associated with the development of leukemia.

Pui is chair of the Department of Oncology at St. Jude; co-leader of the hospital's Hematological Malignancies Program; medical director of the St. Jude International Outreach China Program; and holder of the Fahad Nassar Al-Rashid Chair of Leukemia Research. In addition to his work at St. Jude, Pui helped found the International Childhood ALL Working Group to facilitate international research collaboration and has been helping developing countries access modern leukemia treatments.

Pui, who joined St. Jude in 1977, has authored more than 700 original articles and chapters, edited seven books and monographs, and serves as section editor or editorial board member for several esteemed journals. He is also one of the most highly cited authors in clinical medicine research. Pui's many awards and honors include elected memberships in the Association of American Physicians and the American Society for Clinical Investigation; election as a fellow of the American Association for the Advancement of Science; the American Cancer Society F.M. Kirby Clinical Research Professorship; the 2009 American Association for Cancer Research (AACR) Team Science Award; the 2010 Castle Connolly National Physician of the Year Award; and the 2011 AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Research.


'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert  

Related medicine news :

1. Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
2. BUS Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner
3. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
4. BIDMCs Peter Weller, M.D., receives NIH MERIT Award
5. BIDMC neurologist Bernard Chang, M.D., receives award for epilepsy research
6. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
7. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
8. Donald M. Lloyd-Jones, M.D., recipient of the American Heart Associations 2010 Chairmans Award
9. Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology
10. O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president
11. Anthony S. Fauci, M.D., on results from the CAPRISA 004 microbicide study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ching-Hon Pui, M.D., honored by the American Society of Hematology for work in childhood cancer
(Date:12/7/2016)... ... 07, 2016 , ... ODU, a worldwide leader in ... its advanced highly customizable contact technology solutions. , ODU Single Contact Technology portfolio ... ideal for a wide range of applications that require customization from industries like ...
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are giving ... are not fortunate enough to receive bountiful gifts wrapped tightly under a Christmas Tree. ... to the children of the world. , In exchange for generous donations, customers will ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Facial plastic surgeon, ... holiday season by donating a portion of proceeds to two local organizations: North Chicago ... Animal Control & Friends is a team of authorized and trained volunteers who ...
(Date:12/7/2016)... , ... December 07, 2016 , ... "ProBrand Flip allows ... all media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip ... to use drop zones. Editors can select from a variety of flip book animations. ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a ... to the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation ... she can for this country. , Nancy attributes her patriotic nature to her WWII ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 /PRNewswire/ ... leading RNA medicines company, announced today that it ... to develop RNA-based therapeutics for the treatment of ... Arcturus, wholly-owned therapeutic delivery platform LUNAR™ and UNA ... "Given Takeda,s long-standing commitment to and ...
(Date:12/6/2016)... JOLLA, Calif. , Dec. 6, 2016 /PRNewswire/ ... a biopharmaceutical company leading the discovery and development ... new drug development candidates at its R&D day, ... The first candidate, RGLS5040, is an anti-miR targeting ... The second candidate, RGLS4326, is an anti-miR targeting ...
(Date:12/6/2016)... new study released today by the Alliance for ... Drug Pricing Program will continue to expand at an unprecedented ... exceed $23 billion in total purchases at the 340B price. ... Part B drug reimbursement purchases over the next five years. ... of data on total drug purchases through 340B from 2005 ...
Breaking Medicine Technology: